Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

DOKTA PEER ANALYSIS

Döktas Dökümcülük Ticaret ve Sanayi A.S. — metric-by-metric comparison with peers and the industry median

DOKTADöktas Dökümcülük Ticaret ve Sanayi A.S.

🇹🇷 Turkey · IS · Basic Materials · Steel

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Steel

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial HealthDividend
DOKTAIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
DOKTA+11.7%ASTL-42.8%MTUS+5.5%LIF+3.6%NWPX+223.4%CIA-8.1%
Year-to-Date (YTD)
DOKTA+2.0%ASTL-2.5%MTUS+2.0%LIF-4.9%NWPX+119.1%CIA-33.1%
1-Year
Split-adjusted
DOKTA+11.7%KRDMA-9.4%BMSTL-2.0%KOCMT+97.2%AYES+135.8%CEMTS-2.8%
Year-to-Date (YTD)
DOKTA+2.0%KRDMA+65.4%BMSTL-51.6%KOCMT+78.7%AYES+93.6%CEMTS-12.0%

Key Metric Comparison

P/E

Lower is better
DOKTA—ASTL—MTUS260.69LIF19.47NWPX31.93CIA12.79Median 23.63

ROE

Higher is better
DOKTA-13.9%ASTL-122.4%MTUS0.4%LIF14.5%NWPX10.7%CIA11.4%Median 0.3%

Net Margin

Higher is better
DOKTA-6.1%ASTL-60.0%MTUS0.2%LIF55.7%NWPX7.7%CIA9.5%Median 0.2%

Revenue Growth

Higher is better
DOKTA-4.7%ASTL-20.9%MTUS13.7%LIF-11.4%NWPX10.6%CIA10.9%Median 1.6%

P/E

Lower is better
DOKTA—KRDMA—BMSTL—KOCMT—AYES4.92CEMTS—Median 23.63

ROE

Higher is better
DOKTA-13.9%KRDMA-0.2%BMSTL-3.8%KOCMT-7.4%AYES40.9%CEMTS-3.8%Median 0.3%

Net Margin

Higher is better
DOKTA-6.1%KRDMA-0.3%BMSTL-1.9%KOCMT-4.8%AYES8.6%CEMTS-3.6%Median 0.2%

Revenue Growth

Higher is better
DOKTA-4.7%KRDMA-5.2%BMSTL3.7%KOCMT-8.8%AYES23.5%CEMTS-4.0%Median 1.6%

All Metrics

Valuation
MetricDOKTAASTLMTUSLIFNWPXCIAInd. Median
P/E——260.6919.4731.9312.79●23.63
P/B1.171.681.11●2.813.321.401.34
EV/EBITDA11.40—10.14—18.755.64●12.22
P/S0.540.31●0.6410.852.451.200.79
Financial Health
MetricDOKTAASTLMTUSLIFNWPXCIAInd. Median
Current Ratio0.472.451.732.012.68●2.601.49
Debt/Equity111.8%—1.9%●—25.4%70.4%35.8%
NetDebt/EBITDA5.54—-1.38●—1.161.511.19
Profitability
MetricDOKTAASTLMTUSLIFNWPXCIAInd. Median
Net Margin-6.1%-60.0%0.2%55.7%●7.7%9.5%0.2%
ROE-13.9%-122.4%0.4%14.5%●10.7%11.4%0.3%
ROA-4.9%-44.0%0.3%11.5%●6.9%5.2%0.2%
EBITDA Margin9.2%-43.9%5.5%75.8%●13.9%29.1%8.7%
Growth + Dividend
MetricDOKTAASTLMTUSLIFNWPXCIAInd. Median
Rev. Growth-4.7%-20.9%13.7%●-11.4%10.6%10.9%1.6%
NI Growth———-32.7%27.5%●18.8%17.2%
Div. Yield0.0%2.6%—4.8%●—3.1%0.5%
Payout0.0%-1.3%—107.4%—63.6%0.0%
Valuation
MetricDOKTAKRDMABMSTLKOCMTAYESCEMTSInd. Median
P/E————4.92—23.63
P/B1.170.48●4.780.871.680.731.34
EV/EBITDA11.408.2331.9333.0914.774.45●12.22
P/S0.540.662.590.630.42●0.760.79
Financial Health
MetricDOKTAKRDMABMSTLKOCMTAYESCEMTSInd. Median
Current Ratio0.471.451.181.301.364.41●1.49
Debt/Equity111.8%8.8%●48.3%16.5%52.6%25.9%35.8%
NetDebt/EBITDA5.540.622.36-0.88●0.69-0.281.19
Profitability
MetricDOKTAKRDMABMSTLKOCMTAYESCEMTSInd. Median
Net Margin-6.1%-0.3%-1.9%-4.8%8.6%●-3.6%0.2%
ROE-13.9%-0.2%-3.8%-7.4%40.9%●-3.8%0.3%
ROA-4.9%-0.2%-2.1%-5.1%21.2%●-2.9%0.2%
EBITDA Margin9.2%8.7%8.7%1.8%3.0%16.1%●8.7%
Growth + Dividend
MetricDOKTAKRDMABMSTLKOCMTAYESCEMTSInd. Median
Rev. Growth-4.7%-5.2%3.7%-8.8%23.5%●-4.0%1.6%
NI Growth————1,314.6%—17.2%
Div. Yield0.0%0.0%0.0%0.0%0.0%3.5%●0.5%
Payout0.0%0.0%0.0%0.0%0.0%-73.8%0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on DOKTA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 3, 26. This content is for informational purposes only and is not investment advice.